Neurosteroids and GABA-A receptor function

Frontiers in Endocrinology

Volumn 2, Issue OCT, 2011, Pages

  Wang, Mingde ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Allopregnanolone; GABAA receptor; Pregnenolone sulfate; Premenstrual dysphoric disorder; THDOC

Indexed keywords

EID: 84870905872     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00044     Document Type: Review

References (350)

1. Adkins, C. E., Pillai, G. V., Kerby, J., Bonnert, T. P., Haldon, C., McKernan, R. M., Gonzalez, J. E., Oades, K., Whiting, P. J., and Simpson, P. B. (2001). alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. J. Biol. Chem. 276,38934-38939.
2. Akk, G., Bracamontes, J., and Steinbach,J. H. (2001). Pregnenolone sulfate block of GABA(A) receptors: mechanism and involvement of a residue in the M2 region of the alpha subunit. J. Physiol. (Lond.) 532, 673-684.
3. Akk, G., Li, P., Bracamontes, J., Reichert, D. E., Covey, D. F., and Steinbach, J. H. (2008). Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids. Mol. Pharmacol. 74, 614-627.
4. Akk, G., Shu, H. J., Wang, C., Steinbach, J. H., Zorumski, C. F., Covey, D. F., and Mennerick, S. (2005). Neurosteroid access to the GABAA receptor. J. Neurosci. 25, 11605-11613.
5. Amin,J.,and Weiss,D. S. (1994). Homomeric rho 1 GABA channels: activation properties and domains. Recept. Channels 2, 227-236.
6. Amin, J., and Weiss, D. S. (1996). Insights into the activation mechanism of rho1 GABA receptors obtained by coexpression of wild type and activation-impaired subunits. Proc. Biol. Sci. 263, 273-282.
7. Andreen, L., Sundstrom-Poromaa, I., Bixo, M., Andersson, A., Nyberg, S., and Backstrom, T. (2005). Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroen- docrinology 30, 212-224.
8. Andreen, L., Sundstrom-Poromaa, I., Bixo, M., Nyberg, S., and Backstrom, T. (2006). Allopregnanolone concentrationandmood-abimodal association in postmenopausal women treated with oral progesterone. Psychopharmacology (Berl.) 187, 209-221.
9. Angold, A., Costello, E. J., Erkanli, A., and Worthman, C. M. (1999). Pubertal changes in hormone levels and depression in girls. Psychol. Med. 29, 1043-1053.
10. Backstrom, T. (1976). Epilepsy in women. Oestrogen and progesterone plasma levels. Experientia 32, 248-249.
11. Backstrom, T., Andreen, L., Birzniece, V., Bjorn, I., Johansson, I. M., Nordenstam-Haghjo,M.,Nyberg,S., Sundstrom-Poromaa, I., Wahlstrom, G., Wang, M., and Zhu, D. (2003). The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 17, 325-342.
12. Backstrom, T., Gee, K. W., Lan, N., Sorensen, M., and Wahlstrom, G. (1990). Steroids in relation to epilepsy and anaesthesia. Ciba Found. Symp. 153, 225-230; discussion 230-239.
13. Backstrom, T., Haage, D., Lofgren, M., Johansson, I. M., Stromberg, J., Nyberg, S., Andreen, L., Ossewaarde, L., Wingen, G. A., Turkmen, S., and Bengtsson, S. K. (2011). Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience 191, 46-54.
14. Backstrom, T., Zetterlund, B., Blom, S., and Romano, M. (1984). Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol. Scand. 69, 240-248.
15. Bai,D.,Zhu,G.,Pennefather,P.,Jackson, M. F., MacDonald, J. F., and Orser, B. A. (2001). Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma- aminobutyric acid(A) receptors in hippocampal neurons. Mol. Pharmacol. 59, 814-824.
16. Bali, B., and Kovacs, K. J. (2003). GABAergic control of neuropeptide gene expression in parvocellular neurons of the hypothalamic paraventricular nucleus. Eur. J. Neurosci. 18, 1518-1526.
17. Banerjee, P. K., and Snead, O. C. III. (1998). Neuroactive steroids exacerbate gamma-hydroxybutyric acidinduced absence seizures in rats. Eur. J. Pharmacol. 359, 41-48.
18. Barbaccia, M. L., Concas, A., Serra, M., and Biggio, G. (1998). Stress and neurosteroids in adult and aged rats. Exp. Gerontol. 33, 697-712.
19. Barker, M. J., Greenwood, K. M., Jackson, M., and Crowe, S. F. (2004). Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch. Clin. Neuropsychol. 19, 437-454.
20. Barnes, E. M. Jr. (1996). Use-dependent regulation of GABAA receptors. Int. Rev. Neurobiol. 39, 53-76.
21. Baulieu, E. E., and Robel, P. (1995). Non-genomic mechanisms of action of steroid hormones. Ciba Found. Symp. 191, 24-37; discussion 37-42.
22. Baulieu, E. E., Robel, P., and Schumacher, M. (2007). Neurosteroids: beginning of the story. Int. Rev. Neurobiol. 46, 1-32.
23. Beauchamp, M. H., Ormerod, B. K., Jhamandas, K., Boegman, R. J., and Beninger, R. J. (2000). Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats. Pharmacol. Biochem. Behav. 67, 29-35.
24. Belelli, D., Casula,A., Ling,A., and Lambert, J. J. (2002). The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors. Neuropharmacology 43, 651-661.
25. Belelli, D., and Herd, M. B. (2003). The contraceptive agent Provera enhances GABA(A) receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids? J. Neurosci. 23, 10013-10020.
26. Belelli, D., Herd, M. B., Mitchell, E. A., Peden, D. R., Vardy, A. W., Gentet, L., and Lambert, J. J. (2006). Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience 138, 821-829.
27. Belelli, D., and Lambert, J. J. (2005). Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 6, 565-575.
28. Ben-Porath, D. D., and Taylor, S. P. (2002). The effects of diazepam (valium) and aggressive disposition on human aggression: an experimental investigation. Addict. Behav. 27, 167-177.
29. Bicikova, M., Lapcik, O., Hampl, R., Starka, L., Knuppen, R., Haupt, O., and Dibbelt, L. (1995). A novel radioimmunoassay of allopregnanolone. Steroids 60, 210-213.
30. Biggio, G., Concas, A., Corda, M. G., Giorgi, O., Sanna, E., and Serra, M. (1990). GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol. Ther. 48, 121-142.
31. Birzniece, V., Turkmen, S., Lindblad, C., Zhu, D., Johansson, I. M., Backstrom, T., and Wahlstrom, G. (2006a). GABA(A) receptor changes in acute allopregnanolone tolerance. Eur. J. Pharmacol. 535, 125-134.
32. Birzniece, V., Backstrom, T., Johansson, I. M.,Lindblad,C.,Lundgren,P.,Lofgren, M., Olsson, T., Ragagnin, G., Taube, M., Turkmen, S., Wahlstrom, G.,Wang,M. D.,Wihlback,A. C.,and Zhu,D. (2006b). Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res. Brain Res. Rev. 51, 212-239.
33. Bitran, D., Dugan, M., Renda, P., Ellis, R., and Foley, M. (1999). Anxiolytic effects of the neuroactive steroid pregnanolone (3 alpha-OH-5 betapregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Res. 850, 217-224.
34. Bitran, D., Shiekh, M., and McLeod, M. (1995). Anxiolytic effect of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J. Neuroen- docrinol. 7, 171-177.
35. Bixo, M., Andersson, A., Winblad, B., Purdy, R. H., and Backstrom, T. (1997). Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 764, 173-178.
36. Bjorn, I., Bixo, M., Nojd, K. S., Collberg, P., Nyberg, S., Sundstrom- Poromaa, I., and Backstrom, T. (2002). The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecol. Endocrinol. 16, 1-8.
37. Bjorn, I., Sundstrom-Poromaa, I., Bixo, M., Nyberg, S., Backstrom, G., and Backstrom, T. (2003). Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. J. Clin. Endocrinol. Metab. 88, 2026-2030.
38. Blyth, B. J., Hauger, R. L., Purdy, R. H., and Amico, J. A. (2000). The neurosteroid allopregnanolone modulates oxytocin expression in the hypothalamic paraventricular nucleus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278 R684-R691.
39. Bormann, J. (2000). The 'ABC' of GABA receptors. Trends Pharmacol. Sci. 21, 16-19.
40. Boue-Grabot, E., Taupignon, A., Tramu, G., and Garret, M. (2000). Molecular and electrophysiological evidence for a GABAc receptor in thyrotropin-secreting cells. Endocrinology 141, 1627-1632.
41. Brickley, S. G., Cull-Candy, S. G., and Farrant, M. (1996). Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors. J. Physiol. (Lond.) 497(Pt 3), 753-759.
42. Brickley, S. G., Cull-Candy, S. G., and Farrant, M. (1999). Single-channel properties of synaptic and extrasynaptic GABAA receptors suggest differential targeting of receptor subtypes. J. Neurosci. 19, 2960-2973.
43. Brickley, S. G., Farrant, M., Swanson, G. T., and Cull-Candy, S. G. (2001). CNQX increases GABA- mediated synaptic transmission in the cerebellum by an AMPA/kainate receptor-independent mechanism. Neuropharmacology 41, 730-736.
44. Brown, N., Kerby, J., Bonnert, T. P., Whiting, P. J., and Wafford, K. A. (2002). Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. Br. J. Pharmacol. 136, 965-974.
45. Brunton, P. J., McKay, A. J., Ochedalski, T., Piastowska, A., Rebas, E., Lachowicz, A., and Russell, J. A. (2009). Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone. J. Neurosci. 29, 6449-6460.
46. Brunton, P. J., and Russell, J. A. (2003). Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats. J. Neuroendocrinol. 15, 633-637.
47. Brunton, P. J., and Russell, J. A. (2010). Prenatal social stress in the rat programmes neuroendocrine and behavioural responses to stress in the adult offspring: sex-specific effects. J. Neuroendocrinol. 22, 258-271.
48. Brunton, P. J., and Russell, J. A. (2011). Allopregnanolone and suppressed hypothalamo-pituitary-adrenal axis stress responses in late pregnancy in the rat. Stress 14, 6-12.
49. Brussaard, A. B., Kits, K. S., Baker, R. E., Willems, W. P., Leyting-Vermeulen, J. W., Voorn, P., Smit, A. B., Bicknell,R. J.,and Herbison,A. E. (1997). Plasticity in fast synaptic inhibition of adult oxytocin neurons caused by switch in GABA(A) receptor subunit expression. Neuron 19, 1103-1114.
50. Brzozowski, A. M., Pike, A. C., Dauter, Z., Hubbard, R. E., Bonn, T., Engstrom, O., Ohman, L., Greene, G. L., Gustafsson, J. A., and Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389, 753-758.
51. Burden, P. M., Ai, T. H., Lin, H. Q., Akinci, M., Costandi, M., Hambley, T. M., and Johnston, G. A. (2000). Chiral derivatives of 2-cyclohexylideneperhydro-4,7- methanoindenes, a novel class of nonsteroidal androgen receptor ligand: synthesis, X-ray analysis, and biological activity. J. Med. Chem. 43, 4629-4635.
52. Burgard, E. C., Tietz, E. I., Neelands, T. R., and Macdonald, R. L. (1996). Properties of recombinant gamma- aminobutyric acid A receptor iso- forms containing the alpha 5 sub- unit subtype. Mol. Pharmacol. 50, 119-127.
53. Callachan, H., Cottrell, G. A., Hather, N. Y., Lambert, J. J., Nooney, J. M., and Peters, J. A. (1987). Modulation of the GABAA receptor by progesterone metabolites. Proc. R. Soc. Lond. B Biol. Sci. 231, 359-369.
54. Caraiscos, V. B., Elliott, E. M., You- Ten, K. E., Cheng, V. Y., Belelli, D., Newell, J. G., Jackson, M. F., Lambert, J. J., Rosahl, T. W., Wafford, K. A., MacDonald, J. F., and Orser, B. A. (2004). Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma- aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. U.S.A. 101, 3662-3667.
55. Carl, P., Hogskilde, S., Nielsen, J. W., Sorensen, M. B., Lindholm, M., Karlen, B., and Backstrom, T. (1990). Pregnanolone emulsion. A preliminary pharmacokinetic and pharma- codynamic study of a new intravenous anaesthetic agent. Anaesthesia 45, 189-197.
56. Carter, R. B., Wood, P. L., Wieland, S., Hawkinson, J. E., Belelli, D., Lambert, J. J., White, H. S., Wolf, H. H., Mirsadeghi, S., Tahir, S. H., Bolger, M. B., Lan, N. C., and Gee, K. W. (1997). Characterization of the anti- convulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta- methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor. J. Pharmacol. Exp. Ther. 280, 1284-1295.
57. Casula, M. A., Bromidge, F. A., Pillai, G. V., Wingrove, P. B., Martin, K., Maubach, K., Seabrook, G. R., Whiting, P. J., and Hadingham, K. L. (2001). Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L- 655,708, a benzodiazepine binding site ligand at the GABA(A) receptor. J. Neurochem. 77, 445-451.
58. Celentano, J. J., and Wong, R. K. (1994). Multiphasic desensitization of the GABAA receptor in outside-out patches. Biophys. J. 66, 1039-1050.
59. Celotti, F., Melcangi, R. C., and Martini,L. (1992). The 5 alpha-reductase in the brain: molecular aspects and relation to brain function. Front. Neuroendocrinol. 13, 163-215.
60. Chaudron, L. H., Klein, M. H., Remington, P., Palta, M., Allen, C., and Essex, M. J. (2001). Predictors, prodromes and incidence of postpartum depression. J. Psychosom. Obstet. Gynaecol. 22, 103-112.
61. Chebib, M., Hinton, T., Schmid, K. L., Brinkworth, D., Qian, H., Matos, S., Kim, H. L.,Abdel-Halim, H., Kumar, R. J., Johnston, G. A., and Hanrahan, J. R. (2009). Novel, potent, and selective GABAC antagonists inhibit myopia development and facilitate learning and memory. J. Pharmacol. Exp. Ther. 328, 448-457.
62. Cheney, D. L., Uzunov, D., Costa, E., and Guidotti, A. (1995). Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan- 20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J. Neurosci. 15, 4641-4650.
63. Cherek, D. R., Spiga, R., and Egli, M. (1992). Effects of response requirement and alcohol on human aggressive responding. J. Exp. Anal. Behav. 58, 577-587.
64. Collinson, N., Kuenzi, F. M., Jarolimek, W., Maubach, K. A., Cothliff, R., Sur, C., Smith, A., Out, F. M., Howell, O., Atack, J. R., McKernan, R. M., Seabrook, G. R., Dawson, G. R., Whiting, P. J., and Rosahl, T. W. (2002). Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J. Neurosci. 22, 5572-5580.
65. Compagnone, N. A., and Mellon, S. H. (2000). Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 21, 1-56.
66. Concas, A., Follesa, P., Barbaccia, M. L., Purdy, R. H., and Biggio, G. (1999). Physiological modulation of GABA(A) receptor plasticity by progesterone metabolites. Eur. J. Pharmacol. 375, 225-235.
67. Concas, A., Mostallino, M. C., Perra, C., Lener, R., Roscetti, G., Barbaccia, M. L., Purdy, R. H., and Biggio, G. (1996). Functional correlation between allopregnanolone and [35S]-TBPS binding in the brain of rats exposed to isoniazid, pentylenetetrazol or stress. Br. J. Pharmacol. 118, 839-846.
68. Concas, A., Mostallino, M. C., Porcu, P., Follesa, P., Barbaccia, M. L., Trabucchi, M., Purdy, R. H., Grisenti, P., and Biggio, G. (1998). Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc. Natl. Acad. Sci. U.S.A. 95, 13284-13289.
69. Cooper, E. J., Johnston, G. A., and Edwards, F. A. (1999). Effects of a naturally occurring neurosteroid on GABAA IPSCs during development in rat hippocampal or cerebellar slices. J. Physiol. (Lond.) 521(Pt 2), 437-449.
70. Cope, D. W., Hughes, S. W., and Crunelli, V. (2005). GABAA receptor-mediated tonic inhibition in thalamic neurons. J. Neurosci. 25, 11553-11563.
71. Corpechot, C., Young, J., Calvel, M., Wehrey, C., Veltz, J. N., Touyer, G., Mouren, M., Prasad, V. V., Banner, C., and Sjovall, J. (1993). Neurosteroids: 3 alpha-hydroxy-5 alphapregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology 133, 1003-1009.
72. Covey, D. F., Han, M., Kumar, A. S., de La Cruz, M. A., Meadows, E. S., Hu, Y., Tonnies, A., Nathan, D., Coleman, M., Benz, A., Evers, A. S., Zorumski, C. F., and Mennerick, S. (2000). Neurosteroid analogues. 8. Structure-activity studies of N-acylated 17a-aza- D-homosteroid analogues of the anesthetic steroids (3alpha, 5alpha)- and (3alpha,5beta)-3- hydroxypregnan-20-one. J. Med. Chem. 43, 3201-3204.
73. Crawley, J. N., Glowa, J. R., Majewska, M. D., and Paul, S. M. (1986). Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398, 382-385.
74. Crestani, F., Keist, R., Fritschy, J. M., Benke, D., Vogt, K., Prut, L., Bluthmann, H., Mohler, H., and Rudolph, U. (2002). Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc. Natl. Acad. Sci. U.S.A. 99, 8980-8985.
75. Crestani, F., Lorez, M., Baer, K., Essrich, C., Benke, D., Laurent, J. P., Belzung, C., Fritschy, J. M., Luscher, B.,and Mohler,H. (1999). Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat. Neurosci. 2, 833-839.
76. Davies, P. A., Hanna, M. C., Hales, T. G., and Kirkness, E. F. (1997). Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. Nature 385, 820-823.
77. De Koninck, Y. (2007). Altered chloride homeostasis in neurological disorders: a new target. Curr. Opin. Pharmacol. 7, 93-99.
78. de Quervain, D. J., Roozendaal, B., and McGaugh, J. L. (1998). Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 394, 787-790.
79. Demirgoren, S., Majewska, M. D., Spivak, C. E., and London, E. D. (1991). Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience 45, 127-135.
80. Devor, A., Fritschy, J. M., and Yarom, Y. (2001). Spatial distribution and subunit composition of GABA(A) receptors in the inferior olivary nucleus. J. Neurophysiol. 85, 1686-1696.
81. Dhar, V., and Murphy, B. E. (1990). Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS). Psychoneuroen- docrinology 15, 489-493.
82. Do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M. C., Pelletier, G., and Vaudry, H. (2009). Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides. Front. Neuroendocrinol. 30, 259-301.
83. Dougherty, D. M., Cherek, D. R., and Bennett, R. H. (1996). The effects of alcohol on the aggressive responding of women. J. Stud. Alcohol 57, 178-186.
84. Drasbek, K. R., and Jensen, K. (2006). THIP, a hypnotic and antinociceptive drug, enhances an extrasynaptic GABAA receptor-mediated conductance in mouse neocortex. Cereb. Cortex 16, 1134-1141.
85. Droogleever Fortuyn, H. A., van Broekhoven, F., Span, P. N., Backstrom, T., Zitman, F. G., and Verkes, R. J. (2004). Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology 29, 1341-1344.
86. Drugan, R. C., Morrow, A. L., Weizman, R., Weizman, A., Deutsch, S. I., Crawley, J. N., and Paul, S. M. (1989). Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptormediated chloride ion flux and brain benzodiazepine receptor occupancy. Brain Res. 487, 45-51.
87. Edwards, H. E.,Vimal, S., and Burnham, W. M. (2005). The acute anticonvulsant effects of deoxycorticosterone in developing rats: role of metabolites and mineralocorticoid-receptor responses. Epilepsia 46, 1888-1897.
88. Eisenman, L. N., He, Y., Fields, C., Zorumski, C. F., and Mennerick, S. (2003). Activation dependent properties of pregnenolone sulfate inhibition of GABAA receptor-mediated current. J. Physiol. 550, 679-691.
89. Engstrom, L., Engblom, D., and Blomqvist, A. (2003). Systemic immune challenge induces preproenkephalin gene transcription in distinct autonomic structures of the rat brain. J. Comp. Neurol. 462, 450-461.
90. Essrich, C., Lorez, M., Benson, J. A., Fritschy, J. M., and Luscher, B. (1998). Postsynaptic clustering of major GABAA receptor subtypes requires the gamma 2 subunit and gephyrin. Nat. Neurosci. 1, 563-571.
91. Farrant, M., and Nusser, Z. (2005). Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat. Rev. Neurosci. 6, 215-229.
92. Farrar, S. J., Whiting, P. J., Bonnert, T. P., and McKernan, R. M. (1999). Stoichiometry of a ligand-gatedion channel determined by fluorescence energy transfer. J. Biol. Chem. 274, 10100-10104.
93. Fish, E. W., Faccidomo, S., DeBold, J. F., and Miczek, K. A. (2001). Alcohol, allopregnanolone and aggression in mice. Psychopharmacology (Berl.) 153, 473-483.
94. Fisher, J. L., and Macdonald, R. L. (1997). Single channel properties of recombinant GABAA receptors containing gamma 2 or delta subtypes expressed with alpha 1 and beta 3 subtypes in mouse L929 cells. J. Physiol. 505(Pt 2), 283-297.
95. Flood, J. F., Morley, J. E., and Roberts, E. (1992). Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc. Natl. Acad. Sci. U.S.A. 89, 1567-1571.
96. Flood, J. F., Morley, J. E., and Roberts, E. (1995). Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive. Proc. Natl. Acad. Sci. U.S.A. 92, 10806-10810.
97. Flood, J. F., Smith, G. E., and Roberts, E. (1988). Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res. 447, 269-278.
98. Follesa, P., Concas, A., Porcu, P., Sanna, E., Serra, M., Mostallino, M. C., Purdy, R. H., and Biggio, G. (2001). Role of allopregnanolone in regulation of GABA(A) receptor plasticity during long-term exposure to and withdrawal from progesterone. Brain Res. Brain Res. Rev. 37, 81-90.
99. Follesa, P., Floris, S., Tuligi, G., Mostallino, M. C., Concas, A., and Biggio, G. (1998). Molecular and functional adaptation of the GABA(A) receptor complex during pregnancy and after delivery in the rat brain. Eur. J. Neurosci. 10, 2905-2912.
100. Fortin, D., Adams, R., and Gallez, A. (2004). A blood-brain barrier disruption model eliminating the hemodynamic effect of ketamine. Can. J. Neurol. Sci. 31, 248-253.
101. Freeman, E. W., Sammel, M. D., Liu, L., Gracia, C. R., Nelson, D. B., and Hollander, L. (2004). Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch. Gen. Psychiatry 61, 62-70.
102. Fritschy, J. M., and Brunig, I. (2003). Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol. Ther. 98, 299-323.
103. Frye, C. A. (2001). The role of neurosteroids and non-genomic effects of progestins and androgens in mediating sexual receptivity of rodents. Brain Res. Brain Res. Rev. 37, 201-222.
104. Frye, C. A., Mermelstein, P. G., and DeBold, J. F. (1992). Evidence for a non-genomic action of progestins on sexual receptivity in hamster ventral tegmental area but not hypothalamus. Brain Res. 578, 87-93.
105. Frye, C. A., Van Keuren, K. R., and Erskine, M. S. (1996). Behavioral effects of 3 alpha-androstanediol. I: modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav. Brain Res. 79, 109-118.
106. Galanopoulou, A. S. (2008). Sexually dimorphic expression of KCC2 and GABA function. Epilepsy Res. 80, 99-113.
107. Gallo, M. A., and Smith, S. S. (1993). Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. Pharmacol. Biochem. Behav. 46, 897-904.
108. Garrett, K. M., and Gan, J. (1998). Enhancement of gamma- aminobutyric acidA receptor activity by alpha-chloralose. J. Pharmacol. Exp. Ther. 285, 680-686.
109. Gasior, M., Carter, R. B., and Witkin, J. M. (1999). Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders. Trends Pharmacol. Sci. 20, 107-112.
110. Gee, K. W., Chang, W. C., Brinton, R. E., and McEwen, B. S. (1987). GABA- dependent modulation of the Cl- ionophore by steroids in rat brain. Eur. J. Pharmacol. 136, 419-423.
111. Gee, K. W., and Lan, N. C. (1991). Gamma-aminobutyric acidA receptor complexes in rat frontal cortex and spinal cord show differential responses to steroid modulation. Mol. Pharmacol. 40, 995-999.
112. Genazzani, A. R., Petraglia, F., Bernardi, F., Casarosa, E., Salvestroni, C., Tonetti, A., Nappi, R. E., Luisi, S., Palumbo, M., Purdy, R. H., and Luisi, M. (1998). Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences. J. Clin. Endocrinol. Metab. 83, 2099-2103.
113. Gibbs, T. T., Russek, S. J., and Farb, D. H. (2006). Sulfated steroids as endogenous neuromodulators. Pharmacol. Biochem. Behav. 84, 555-567.
114. Glykys, J., Mann, E. O., and Mody, I. (2008). Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus? J. Neurosci. 28, 1421-1426.
115. Glykys, J., and Mody, I. (2006). Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA A receptor alpha5 subunit-deficient mice. J. Neurophysiol. 95, 2796-2807.
116. Glykys, J., and Mody, I. (2007). The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus. J. Physiol. (Lond.) 582, 1163-1178.
117. Grishkovskaya, I., Avvakumov, G. V., Sklenar, G., Dales, D., Hammond, G. L., and Muller, Y. A. (2000). Crystal structure of human sex hormonebinding globulin: steroid transport by a laminin G-like domain. EMBO J. 19, 504-512.
118. Grobin, A. C., and Morrow, A. L. (2000). 3alpha-hydroxy-5alphapregnan-20-one exposure reduces GABA(A) receptor alpha4 subunit mRNA levels. Eur. J. Pharmacol. 409, R1-R2.
119. Grunewald, R. A., Aliberti, V., and Panayiotopoulos, C. P. (1992). Exacerbation of typical absence seizures by progesterone. Seizure 1, 137-138.
120. Gulacsi, A., Lee, C. R., Sik, A., Viitanen, T., Kaila, K., Tepper, J. M., and Freund, T. F. (2003). Cell type-specific differences in chloride-regulatory mechanisms and GABA(A) receptor-mediated inhibition in rat substantia nigra. J. Neurosci. 23, 8237-8246.
121. Gulinello, M., Gong, Q. H., Li, X., and Smith, S. S. (2001). Short-term exposure to a neuroactive steroid increases alpha4 GABA(A) receptor subunit levels in association with increased anxiety in the female rat. Brain Res. 910, 55-66.
122. Gyermek, L., Iriarte, J., and Crabbe, P. (1968). Steroids. CCCX. Structure- activity relationship of some steroidal hypnotic agents. J. Med. Chem. 11, 117-125.
123. Gyermek, L., and Soyka, L. F. (1975). Steroid anesthetics. Anesthesiology 42, 331-344.
124. Haage, D., Backstrom, T., and Johansson, S. (2005). Interaction between allopregnanolone and pregnenolone sulfate in modulating GABA-mediated synaptic currents in neurons from the rat medial preoptic nucleus. Brain Res. 1033, 58-67.
125. Haage, D., Druzin, M., and Johansson, S. (2002). Allopregnanolone modulates spontaneous GABA release via presynaptic Cl- permeability in rat preoptic nerve terminals. Brain Res. 958, 405-413.
126. Haage, D., and Johansson, S. (1999). Neurosteroid modulation of synaptic and GABA-evoked currents in neurons from the rat medial preoptic nucleus. J. Neurophysiol. 82, 143-151.
127. Haas,K. F.,and Macdonald,R. L. (1999). GABAA receptor subunit gamma2 and delta subtypes confer unique kinetic properties on recombinant GABAA receptor currents in mouse fibroblasts. J. Physiol. (Lond.) 514(Pt 1), 27-45.
128. Hadingham, K. L., Wingrove, P. B., Wafford, K. A., Bain, C., Kemp, J. A., Palmer, K. J., Wilson, A. W., Wilcox, A. S., Sikela, J. M., and Ragan, C. I. (1993). Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid typeAreceptors.Mol. Pharmacol. 44, 1211-1218.
129. Halbreich, U. (2003). The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneu- roendocrinology 28(Suppl. 3), 55-99.
130. Hamann, M., Rossi, D. J., and Attwell, D. (2002). Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex. Neuron 33, 625-633.
131. Hamilton, N. M. (2002). Interaction of steroids with the GABA(A) receptor. Curr. Top. Med. Chem. 2, 887-902.
132. Harney, S. C., Frenguelli, B. G., and Lambert, J. J. (2003). Phosphorylation influences neurosteroid modulation of synaptic GABAA receptors in rat CA1 and dentate gyrus neurones. Neuropharmacology 45, 873-883.
133. Harris, R. A., Proctor, W. R., McQuilkin, S. J.,Klein,R. L.,Mascia,M. P.,Whatley, V., Whiting, P. J., and Dunwiddie, T. V. (1995). Ethanol increases GABAA responses in cells stably transfected with receptor subunits. Alcohol. Clin. Exp. Res. 19, 226-232.
134. Havlikova, H., Hill, M., Kancheva, L., Vrbikova, J., Pouzar, V., Cerny, I., Kancheva, R., and Starka, L. (2006). Serum profiles of free and conjugated neuroactive pregnanolone isomers in nonpregnant women of fertile age. J. Clin. Endocrinol. Metab. 91, 3092-3099.
135. Hawkinson, J. E., Kimbrough, C. L., Belelli, D., Lambert, J. J., Purdy, R. H., and Lan, N. C. (1994a). Correlation of neuroactive steroid modulation of [35S]t- butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function. Mol. Pharmacol. 46, 977-985.
136. Hawkinson, J. E., Kimbrough, C. L., McCauley, L. D., Bolger, M. B., Lan, N. C., and Gee, K. W. (1994b). The neuroactive steroid 3 alphahydroxy-5 beta-pregnan-20-one is a two-component modulator of ligand binding to the GABAA receptor. Eur. J. Pharmacol. 269, 157-163.
137. Henderson, V. W., Paganini-Hill, A., Emanuel, C. K., Dunn, M. E., and Buckwalter, J. G. (1994). Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch. Neurol. 51, 896-900.
138. Hill, M., Bicikova, M., Parizek, A., Havlikova, H., Klak, J., Fajt, T., Meloun, M., Cibula, D., Cegan, A., Sulcova, J., Hampl, R., and Starka, L. (2001). Neuroactive steroids, their precursors and polar conjugates during parturition and postpartum in maternal blood: 2. Time profiles of pregnanolone isomers. J. Steroid Biochem. Mol. Biol. 78, 51-57.
139. Hillen, T., Lun, A., Reischies, F. M., Borchelt, M., Steinhagen-Thiessen, E., and Schaub, R. T. (2000). DHEA- S plasma levels and incidence of Alzheimer's disease. Biol. Psychiatry 47, 161-163.
140. Hogenkamp, D. J., Tahir, S. H., Hawkinson, J. E., Upasani, R. B., Alauddin, M., Kimbrough, C. L., AcostaBurruel, M., Whittemore, E. R., Woodward, R. M., Lan, N. C., Gee, K. W., and Bolger, M. B. (1997). Synthesis and in vitro activity of 3 beta-substituted-3 alpha- hydroxypregnan-20-ones: allosteric modulators of the GABAA receptor. J. Med. Chem. 40, 61-72.
141. Hosie, A. M., Clarke, L., da Silva, H., and Smart, T. G. (2009). Conserved site for neurosteroid modulation of GABA A receptors. Neuropharma- cology 56, 149-154.
142. Hosie, A. M., Dunne, E. L., Harvey, R. J., and Smart, T. G. (2003). Zinc- mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity. Nat. Neurosci. 6, 362-369.
143. Hosie, A. M., Wilkins, M. E., da Silva, H. M., and Smart, T. G. (2006). Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites. Nature 444, 486-489.
144. Hosie, A. M., Wilkins, M. E., and Smart, T. G. (2007). Neurosteroid binding sites on GABA(A) receptors. Pharmacol. Ther. 116, 7-19.
145. Hutcheon, B., Morley, P., and Poulter, M. O. (2000). Developmental change in GABAA receptor desensitization kinetics and its role in synapse function in rat cortical neurons. J. Physiol. (Lond.) 522(Pt 1), 3-17.
146. Imamura, M., and Prasad, C. (1998). Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem. Biophys. Res. Commun. 243, 771-775.
147. Jia, F., Pignataro, L., Schofield, C. M., Yue, M., Harrison, N. L., and Goldstein, P. A. (2005). An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons. J. Neurophysiol. 94, 4491-4501.
148. Johansson, I. M., Birzniece, V., Lindblad, C., Olsson, T., and Backstrom, T. (2002). Allopregnanolone inhibits learning in the Morris water maze. Brain Res. 934, 125-131.
149. Jones, M. V., and Westbrook, G. L. (1995). Desensitized states prolong GABAA channel responses to brief agonist pulses. Neuron 15, 181-191.
150. Kahle, K. T., Staley, K. J., Nahed, B. V., Gamba, G., Hebert, S. C., Lifton, R. P., and Mount, D. B. (2008). Roles of the cation-chloride cotransporters in neurological disease. Nat. Clin. Pract. Neurol. 4, 490-503.
151. Kancheva, L., Havlikova, H., Hill, M., Vrbikova, J., and Starka, L. (2007). "Neuroactive steroids in adult men," in 4th International Meeting - Steroids and Nervous system, Torino, 152.
152. Kendell,R. E.,McGuire,R. J.,Connor,Y., and Cox, J. L. (1981). Mood changes in the first three weeks after childbirth. J. Affect. Disord. 3, 317-326.
153. Kennedy, R. T., Thompson, J. E., and Vickroy, T. W. (2002). In vivo monitoring of amino acids by direct sampling of brain extracellular fluid at ultralow flow rates and capillary electrophoresis. J. Neurosci. Methods 114, 39-49.
154. Kerr, D. I., and Ong, J. (1992). GABA agonists and antagonists. Med. Res. Rev. 12, 593-636.
155. Khirug, S., Yamada, J., Afzalov, R., Voipio, J., Khiroug, L., and Kaila, K. (2008). GABAergic depolarization of the axon initial segment in cortical principal neurons is caused by the Na-K-2Cl cotransporter NKCC1. J. Neurosci. 28, 4635-4639.
156. Kittler, J. T., Wang, J., Connolly, C. N., Vicini, S., Smart, T. G., and Moss, S. J. (2000). Analysis of GABAA receptor assembly in mammalian cell lines and hippocampal neurons using gamma 2 subunit green fluorescent protein chimeras. Mol. Cell. Neurosci. 16, 440-452.
157. Klangkalya, B., and Chan, A. (1988). Structure-activity relationships of steroid hormones on muscarinic receptor binding. J. Steroid Biochem. 29, 111-118.
158. Klausberger, T., Ehya, N., Fuchs, K., Fuchs, T., Ebert, V., Sarto, I., and Sieghart, W. (2001). Detection and binding properties of GABA(A) receptor assembly intermediates. J. Biol. Chem. 276, 16024-16032.
159. Knight, A. R., Stephenson, F. A., Tallman, J. F., and Ramabahdran, T. V. (2000). Monospecific antibodies as probes for the stoichiometry of recombinant GABA(A) receptors. Recept. Channels 7, 213-226.
160. Koksma, J. J., van Kesteren, R. E., Rosahl, T. W., Zwart, R., Smit, A. B., Luddens, H., and Brussaard, A. B. (2003). Oxytocin regulates neurosteroid modulation of GABA(A) receptors in supraoptic nucleus around parturition. J. Neurosci. 23, 788-797.
161. Korpi, E. R., Debus, F., Linden, A. M., Malecot, C., Leppa, E., Vekovis- cheva, O., Rabe, H., Bohme, I., Aller, M. I., Wisden, W., and Luddens, H. (2007). Does ethanol act preferentially via selected brain GABAA receptor subtypes? The current evidence is ambiguous. Alcohol 41, 163-176.
162. Kurthen, M., Linke, D. B., Reuter, B. M., Hufnagel, A., and Elger, C. E. (1991). Severe negative emotional reactions in intracarotid sodium amytal procedures: further evidence for hemispheric asymmetries? Cortex 27, 333-337.
163. Lambert, J. J., Belelli, D., Hill-Venning, C., Callachan, H., and Peters, J. A. (1996). Neurosteroid modulation of native and recombinant GABAA receptors. Cell.Mol.Neurobiol.16, 155-174.
164. Lambert, J. J., Belelli, D., Hill-Venning, C., and Peters, J. A. (1995). Neuros- teroids and GABAA receptor function. Trends Pharmacol. Sci. 16, 295-303.
165. Lambert, J. J., Harney, S. C., Belelli, D., and Peters, J. A. (2001a). Neurosteroid modulation of recombinant and synaptic GABAA receptors. Int. Rev. Neurobiol. 46, 177-205.
166. Lambert, J. J., Belelli, D., Harney, S. C., Peters, J. A., and Frenguelli, B. G. (2001b). Modulation of native and recombinant GABA(A) receptors by endogenous and synthetic neuroac- tive steroids. Brain Res. Brain Res. Rev. 37, 68-80.
167. Landgren, S., Aasly, J., Backstrom, T., Dubrovsky, B., and Danielsson, E. (1987). The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex. Acta Physiol. Scand. 131, 33-42.
168. Landgren, S., Wang, M. D., Backstrom, T., and Johansson, S. (1998). Interaction between 3 alpha-hydroxy- 5 alpha-pregnan-20-one and car- bachol in the control of neuronal excitability in hippocampal slices of female rats in defined phases of the oestrus. Acta Physiol. Scand. 162, 77-88.
169. Lanthier, A., and Patwardhan, V. V. (1986). Sex steroids and 5-en-3 beta- hydroxysteroids in specific regions of the human brain and cranial nerves. J. Steroid Biochem. 25, 445-449.
170. Laubach,G. D.,P'An,S.Y.,and Rudel,H. W. (1955). Steroid anesthetic agent. Science 122, 78.
171. Lavoie, A. M., Tingey, J. J., Harrison, N. L., Pritchett, D. B., and Twyman, R. E. (1997). Activation and deactivation rates of recombinant GABA(A) receptor channels are dependent on alpha-subunit isoform. Biophys. J. 73, 2518-2526.
172. Lee, G. P., Loring, D. W., Meador, K. J., Flanigin, H. F., and Brooks, B. S. (1988). Severe behavioral complications following intracarotid sodium amobarbital injection: implications for hemispheric asymmetry of emotion. Neurology 38, 1233-1236.
173. Lerma, J., Herranz, A. S., Herreras, O., Abraira, V., and Martin del Rio, R. (1986). In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis. Brain Res. 384, 145-155.
174. Leroy, C., Poisbeau, P., Keller, A. F., and Nehlig, A. (2004). Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy. J. Physiol. (Lond.) 557, 473-487.
175. Li, G. D., Chiara, D. C., Cohen, J. B., and Olsen, R. W. (2009). Neurosteroids allosterically modulate binding of the anesthetic etomidate to gamma- aminobutyric acid type A receptors. J. Biol. Chem. 284, 11771-11775.
176. Li, P., Khatri, A., Bracamontes, J., Weiss, D. S., Steinbach, J. H., and Akk, G. (2010). Site-specific fluorescence reveals distinct structural changes induced in the human rho 1 GABA receptor by inhibitory neurosteroids. Mol. Pharmacol. 77, 539-546.
177. Li, W., Jin, X., Covey, D. F., and Steinbach, J. H. (2007). Neuroactive steroids and human recombinant rho1 GABAC receptors. J. Pharmacol. Exp. Ther. 323, 236-247.
178. Liang, J., Cagetti, E., Olsen, R. W., and Spigelman, I. (2004). Altered pharmacology of synaptic and extrasynaptic GABAA receptors on CA1 hippocampal neurons is consistent with subunit changes in a model of alcohol withdrawal and dependence. J. Pharmacol. Exp. Ther. 310, 1234-1245.
179. Lofgren, M., Johansson, I. M., Meyerson, B., Lundgren, P., and Backstrom, T. (2006). Progesterone withdrawal effects in the open field test can be predicted by elevated plus maze performance. Horm. Behav. 50, 208-215.
180. Luisi, S., Petraglia, F., Benedetto, C., Nappi, R. E., Bernardi, F., Fadalti, M., Reis, F. M., Luisi, M., and Genazzani, A. R. (2000). Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. J. Clin. Endocrinol. Metab. 85, 2429-2433.
181. Lundgren, P., Stromberg, J., Backstrom, T., and Wang, M. (2003). Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3beta- hydroxy-5alpha-pregnan-20-one (isoallopregnanolone). Brain Res. 982, 45-53.
182. Lupien, S. J., Fiocco, A., Wan, N., Maheu, F., Lord, C., Schramek, T., and Tu, M. T. (2005). Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 30, 225-242.
183. Macdonald, R. L., and Olsen, R. W. (1994). GABAA receptor channels. Annu.Rev.Neurosci.17, 569-602.
184. Maione, S., Berrino, L., Vitagliano, S., Leyva, J., and Rossi, F. (1992). Pregnenolone sulfate increases the convulsant potency of N-methyl-D- aspartate in mice. Eur. J. Pharmacol. 219, 477-479.
185. Maitra, R., and Reynolds, J. N. (1998). Modulation of GABA(A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA(A) receptor isoforms. Can. J. Physiol. Pharmacol. 76, 909-920.
186. Maitra, R., and Reynolds, J. N. (1999). Subunit dependent modulation of GABAA receptor function by neuroactive steroids. Brain Res. 819, 75-82.
187. Majewska, M. D. (1992). Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38, 379-395.
188. Majewska, M. D., Demirgoren, S., Spivak, C. E., and London, E. D. (1990). The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 526, 143-146.
189. Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., and Paul, S. M. (1986). Steroid hormone metabolites are barbituratelike modulators of the GABA receptor. Science 232, 1004-1007.
190. Majewska, M. D., Mienville, J. M., and Vicini, S. (1988). Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci. Lett. 90, 279-284.
191. Majewska, M. D., and Schwartz, R. D. (1987). Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain? Brain Res. 404, 355-360.
192. Martina, M., Royer, S., and Pare, D. (2001). Cell-type-specific GABA responses and chloride homeostasis in the cortex and amygdala. J. Neurophysiol. 86, 2887-2895.
193. Masia, S. L., Perrine, K., Westbrook, L., Alper, K., and Devinsky, O. (2000). Emotional outbursts and post-traumatic stress disorder during intracarotid amobarbital procedure. Neurology 54, 1691-1693.
194. Maubach, K. (2003). GABA(A) receptor subtype selective cognition enhancers. Curr. Drug Targets CNS Neurol. Disord. 2, 233-239.
195. Mayo,W.,Dellu,F.,Robel,P.,Cherkaoui, J., Le Moal, M., Baulieu, E. E., and Simon, H. (1993). Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat. Brain Res. 607, 324-328.
196. McEwen, B. S. (1991). Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12, 141-147.
197. McKernan, R. M., and Whiting, P. J. (1996). Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci. 19, 139-143.
198. Mehta, A. K., and Ticku, M. K. (1999). An update on GABAA receptors. Brain Res. Brain Res. Rev. 29, 196-217.
199. Melchior, C. L., and Ritzmann, R. F. (1996). Neurosteroids block the memory-impairing effects of ethanol in mice. Pharmacol. Biochem. Behav. 53, 51-56.
200. Mellon, S. H. (2007). Neurosteroid regulation of central nervous system development. Pharmacol. Ther. 116, 107-124.
201. Mellon, S. H., Griffin, L. D., and Compagnone, N. A. (2001). Biosynthesis and action of neurosteroids. Brain Res. Brain Res. Rev. 37, 3-12.
202. Mennerick, S., He, Y., Jiang, X., Manion, B. D., Wang, M., Shute, A., Benz, A., Evers,A. S., Covey, D. F., and Zorumski, C. F. (2004). Selective antagonism of 5alpha-reduced neurosteroid effects at GABA(A) receptors. Mol. Pharmacol. 65, 1191-1197.
203. Mennerick, S., Zeng, C. M., Benz, A., Shen, W., Izumi, Y., Evers, A. S., Covey, D. F., and Zorumski, C. F. (2001). Effects on gammaaminobutyric acid (GABA)(A) receptors of a neuroactive steroid that negatively modulates glutamate neurotransmission and augments GABA neurotransmission. Mol. Pharmacol. 60, 732-741.
204. Mensah-Nyagan, A. G., Do-Rego, J. L., Beaujean, D., Luu-The, V., Pelletier, G., and Vaudry, H. (1999). Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 51, 63-81.
205. Meyerson, B. J. (1967). Relationship between the anesthetic and gestagenic action and estrous behavior-inducing activity of different progestins. Endocrinology 81, 369-374.
206. Miczek, K. A., Fish, E. W., and De Bold, J. F. (2003). Neurosteroids, GABAA receptors, and escalated aggressive behavior. Horm. Behav. 44, 242-257.
207. Mienville, J. M., and Vicini, S. (1989). Pregnenolone sulfate antagonizes GABAA receptor-mediated currents via a reduction of channel opening frequency. Brain Res. 489, 190-194.
208. Mihalek, R. M., Banerjee, P. K., Korpi, E. R., Quinlan, J. J., Firestone, L. L., Mi, Z. P., Lagenaur, C., Tretter, V., Sieghart, W., Anagnostaras, S. G., Sage, J. R., Fanselow, M. S., Guidotti, A., Spigelman, I., Li, Z., DeLorey, T. M., Olsen, R. W., and Homanics, G. E. (1999). Attenuated sensitivity to neuroactive steroids in gamma- aminobutyrate type A receptor delta subunit knockout mice. Proc. Natl. Acad. Sci. U.S.A. 96, 12905-12910.
209. Miklos, I. H., and Kovacs, K. J. (2002). GABAergic innervation of corticotropin-releasing hormone (CRH)-secreting parvocellular neurons and its plasticity as demonstrated by quantitative immunoelectron microscopy. Neuroscience 113, 581-592.
210. Miller, L. G., Greenblatt, D. J., Barnhill, J. G., and Shader, R. I. (1988). Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma- aminobutyric acidA receptor function. J. Pharmacol. Exp. Ther. 246, 170-176.
211. Mitchell, E. A., Herd, M. B., Gunn, B. G., Lambert, J. J., and Belelli, D. (2008). Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease. Neurochem. Int. 52, 588-595.
212. Mitchell, S. J., and Silver, R. A. (2003). Shunting inhibition modulates neuronal gain during synaptic excitation. Neuron 38, 433-445.
213. Mody, I. (2001). Distinguishing between GABA(A) receptors responsible for tonic and phasic conductances. Neurochem. Res. 26, 907-913.
214. Mody, I. (2008). Extrasynaptic GABAA receptors in the crosshairs of hormones and ethanol. Neurochem. Int. 52, 60-64.
215. Mody, I., De Koninck, Y., Otis, T. S., and Soltesz, I. (1994). Bridging the cleft at GABA synapses in the brain. Trends Neurosci. 17, 517-525.
216. Moenter, S. M., and DeFazio, R. A. (2005). Endogenous gamma- aminobutyric acid can excite gonadotropin-releasing hormone neurons. Endocrinology 146, 5374-5379.
217. Mohammed, A. K., Wahlstrom, G., Tiger, G., Bjorklund, P. E., Stenstrom, A., Magnusson, O., Archer, T., Fowler, C. J., and Nordberg, A. (1987). Impaired performance of rats in the Morris swim-maize test late in abstinence following longterm sodium barbital treatment. Drug Alcohol Depend. 20, 203-212.
218. Mohler, H., Crestani, F., and Rudolph, U. (2001). GABA(A)-receptor subtypes: a new pharmacology. Curr. Opin. Pharmacol. 1, 22-25.
219. Mohler, H., Fritschy, J. M., Crestani, F., Hensch, T., and Rudolph, U. (2004). Specific GABA(A) circuits in brain development and therapy. Biochem. Pharmacol. 68, 1685-1690.
220. Mohler, H., Fritschy, J. M., and Rudolph, U. (2002). A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther. 300, 2-8.
221. Morris, K. D., Moorefield, C. N., and Amin, J. (1999). Differential modulation of the gamma-aminobutyric acid type C receptor by neuroactive steroids. Mol. Pharmacol. 56, 752-759.
222. Mozrzymas, J. W., Zarnowska, E. D., Pytel, M., and Mercik, K. (2003). Modulation of GABA(A) receptors by hydrogen ions reveals synaptic GABA transient and a crucial role of the desensitization process. J. Neurosci. 23, 7981-7992.
223. Nakamura, N. H., Rosell, D. R., Akama, K. T., and McEwen, B. S. (2004). Estrogen and ovariectomy regulate mRNA and protein of glutamic acid decarboxylases and cation-chloride cotransporters in the adult rat hippocampus. Neuroendocrinology 80, 308-323.
224. Nasman, B., Olsson, T., Backstrom, T., Eriksson, S., Grankvist, K., Viitanen, M., and Bucht, G. (1991). Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multiinfarct dementia. Biol. Psychiatry 30, 684-690.
225. Nasman, B., Olsson, T., Fagerlund, M., Eriksson, S., Viitanen, M., and Carlstrom, K. (1996). Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol. Psychiatry 39, 311-318.
226. Nasman, B., Olsson, T., Viitanen, M., and Carlstrom, K. (1995). A subtle disturbance in the feedback regulation of the hypothalamic-pituitaryadrenal axis in the early phase of Alzheimer's disease. Psychoneuro-endocrinology 20, 211-220.
227. Nayeem, N., Green, T. P., Martin, I. L., and Barnard, E. A. (1994). Quaternary structure of the native GABAA receptor determined by electron microscopic image analysis. J. Neurochem. 62, 815-818.
228. Nguyen, Q., Sapp, D. W., Van Ness, P. C., and Olsen, R. W. (1995). Modulation of GABAA receptor binding in human brain by neuroactive steroids: species and brain regional differences. Synapse 19, 77-87.
229. Nusser, Z., Cull-Candy, S., and Farrant, M. (1997). Differences in synaptic GABA(A) receptor number underlie variation in GABA mini amplitude. Neuron 19, 697-709.
230. Nusser, Z., and Mody, I. (2002). Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J. Neurophysiol. 87, 2624-2628.
231. Nusser, Z., Sieghart, W., and Somogyi, P. (1998). Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J. Neurosci. 18, 1693-1703.
232. Nyberg, S., Wahlstrom, G., Backstrom, T., and Sundstrom Poromaa, I. (2004). Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder. Psychoneuroen- docrinology 29, 767-777.
233. Ottander, U., Poromaa, I. S., Bjurulf, E., Skytt, A., Backstrom, T., and Olofsson, J. I. (2005). Allopregnanolone and pregnanolone are produced by the human corpus luteum. Mol. Cell. Endocrinol. 239, 37-44.
234. Park-Chung, M., Malayev, A., Purdy, R. H., Gibbs, T. T., and Farb, D. H. (1999). Sulfated and unsulfated steroids modulate gamma- aminobutyric acidA receptor function through distinct sites. Brain Res. 830, 72-87.
235. Parry, B. L. (2001). The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications. CNS Drugs 15, 277-285.
236. Paul, S. M., and Purdy, R. H. (1992). Neuroactive steroids. FASEB J. 6, 2311-2322.
237. Pirker,S.,Schwarzer,C.,Wieselthaler,A., Sieghart, W., and Sperk, G. (2000). GABA(A) receptors: immunocyto- chemical distribution of 13 subunits in the adult rat brain. Neuroscience 101, 815-850.
238. Poisbeau, P., Feltz, P., and Schlichter, R. (1997). Modulation of GABAA receptor-mediated IPSCs by neuroactive steroids in a rat hypothalamo-hypophyseal coculture model. J. Physiol. (Lond.) 500(Pt 2), 475-485.
239. Porcello, D. M., Huntsman, M. M., Mihalek, R. M., Homanics, G. E., and Huguenard, J. R. (2003). Intact synaptic GABAergic inhibition and altered neurosteroid modulation of thalamic relay neurons in mice lacking delta subunit. J. Neurophysiol. 89, 1378-1386.
240. Prescott, S. A., Sejnowski, T. J., and De Koninck, Y. (2006). Reduction of anion reversal potential subverts the inhibitory control of firing rate in spinal lamina I neurons: towards a biophysical basis for neuropathic pain. Mol. Pain 2, 32.
241. Price, T. J., Cervero, F., and de Koninck, Y. (2005). Role of cation-chloride- cotransporters (CCC) in pain and hyperalgesia. Curr. Top. Med. Chem. 5, 547-555.
242. Price, T. J., Cervero, F., Gold, M. S., Hammond, D. L., and Prescott, S. A. (2009). Chloride regulation in the pain pathway. Brain Res. Rev. 60, 149-170.
243. Puia, G., Ducic, I., Vicini, S., and Costa, E. (1993). Does neurosteroid modulatory efficacy depend on GABAA receptor subunit composition? Recept. Channels 1, 135-142.
244. Puia, G., Santi, M. R., Vicini, S., Pritchett, D. B., Purdy, R. H., Paul, S. M., Seeburg, P. H., and Costa, E. (1990). Neurosteroids act on recombinant human GABAA receptors. Neuron 4, 759-765.
245. Purdy, R. H., Moore, P. H. Jr., Morrow, A. L., and Paul, S. M. (1992). Neurosteroids and GABAA receptor function. Adv. Biochem. Psychopharmacol. 47, 87-92.
246. Purdy, R. H., Morrow, A. L., Blinn, J. R., and Paul, S. M. (1990). Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptormediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J. Med. Chem. 33, 1572-1581.
247. Purdy, R. H., Morrow, A. L., Moore, P. H. Jr., and Paul, S. M. (1991). Stress- induced elevations of gamma- aminobutyric acid type A receptoractive steroids in the rat brain. Proc. Natl. Acad. Sci. U.S.A. 88, 4553-4557.
248. Purvez, D., Augustine, G. J., Fitzpatrick, D., Hall, W. C., LaMantia, A. S., McNamara, J. O., and Williams, S. M. (2004). Neuroscience, 3rd Edn. Sunderland: Sinauer Associates Inc., 143.
249. Ragagnin, G., Rahman, M., Zingmark, E., Stromberg, J., Lundgren, P., Wang, M., and Backstrom, T. (2007). "Structure actvity relationship of GABAA-steroids antagonists," in 4th International Meeting - Steroids and Nervous system, Torino, 197.
250. Rahman, M., Lindblad, C., Johansson, I. M., Backstrom, T., and Wang, M. D. (2006). Neurosteroid modulation of recombinant rat alpha(5)beta(2)gamma(2L) and alpha(1)beta(2)gamma(2L) GABA(A) receptors in Xenopus oocyte. Eur. J. Pharmacol. 547, 37-44.
251. Rasmuson, S., Andrew, R., Nasman, B., Seckl, J. R., Walker, B. R., and Olsson, T. (2001). Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease. Biol. Psychiatry 49, 547-552.
252. Reddy, D. S. (2003). Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol. Sci. 24, 103-106.
253. Reddy, D. S., and Kulkarni, S. K. (2000). Development of neurosteroid-based novel psychotropic drugs. Prog. Med. Chem. 37, 135-175.
254. Reddy, D. S., and Rogawski, M. A. (2002). Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility. J. Neurosci. 22, 3795-3805.
255. Rick, C. E., Ye, Q., Finn, S. E., and Harrison, N. L. (1998). Neurosteroids act on the GABA(A) receptor at sites on the N-terminal side of the middle of TM2. Neuroreport 9, 379-383.
256. Riedel, G., Platt, B., and Micheau, J. (2003). Glutamate recep- tor function in learning and memory. Behav. Brain Res. 140, 1-47.
257. Rodgers, R. J., and Johnson, N. J. (1998). Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice. Pharmacol. Biochem. Behav. 59, 221-232.
258. Rudolph, U., Crestani, F., Benke, D., Brunig, I., Benson, J. A., Fritschy, J. M., Martin, J. R., Bluethmann, H., and Mohler, H. (1999). Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401, 796-800.
259. Rudolph, U., Crestani, F., and Mohler, H. (2001). GABA(A) receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol. Sci. 22, 188-194.
260. Rupprecht, R. (2003). Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28, 139-168.
261. Rupprecht, R., di Michele, F., Hermann, B., Strohle, A., Lancel, M., Romeo, E.,and Holsboer,F. (2001). Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res. Brain Res. Rev. 37, 59-67.
262. Rupprecht, R., Reul, J. M., Trapp, T., van Steensel, B., Wetzel, C., Damm, K., Zieglgansberger, W., and Holsboer, F. (1993). Progesterone receptormediated effects of neuroactive steroids. Neuron 11, 523-530.
263. Sandstrom, A., Rhodin, I. N., Lundberg, M., Olsson, T., and Nyberg, L. (2005). Impaired cognitive performance in patients with chronic burnout syndrome. Biol. Psychol. 69, 271-279.
264. Sanna, E., Murgia, A., Casula, A., and Biggio, G. (1997). Differential subunit dependence of the actions of the general anesthetics alphaxalone and etomidate at gamma-aminobutyric acid type A receptors expressed in Xenopus laevis oocytes. Mol. Pharmacol. 51, 484-490.
265. Saunders, P. A., Copeland, J. R., Dewey, M. E., Davidson, I. A., McWilliam, C., Sharma, V., and Sullivan, C. (1991). Heavy drinking as a risk factor for depression and dementia in elderly men. Findings from the Liverpool longitudinal community study. Br. J. Psychiatry 159, 213-216.
266. Saxena, N. C., and Macdonald, R. L. (1994). Assembly of GABAA receptor subunits: role of the delta subunit. J. Neurosci. 14, 7077-7086.
267. Saxena, N. C., and Macdonald, R. L. (1996). Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms. Mol. Pharmacol. 49, 567-579.
268. Schofield, P. R., Darlison, M. G., Fujita, N., Burt, D. R., Stephenson, F. A., Rodriguez, H., Rhee, L. M., Ramachandran, J., Reale, V., Glencorse, T. A., Seeburg, P. H., and Barnard, E. A. (1987). Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family. Nature 328, 221-227.
269. Schumacher, M., Akwa, Y., Guennoun, R., Robert, F., Labombarda, F., Desarnaud, F., Robel, P., De Nicola, A. F., and Baulieu, E. E. (2000). Steroid synthesis and metabolism in the nervous system: trophic and protective effects. J. Neurocytol. 29, 307-326.
270. Sear, J. W. (1997). ORG 21465, a new water-soluble steroid hypnotic: more of the same or something different? Br. J. Anaesth. 79, 417-419.
271. Semyanov, A., Walker, M. C., and Kullmann, D. M. (2003). GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat. Neurosci. 6, 484-490.
272. Semyanov, A., Walker, M. C., Kullmann, D. M., and Silver, R. A. (2004). Tonically active GABA A receptors: modulating gain and maintaining the tone. Trends Neurosci. 27, 262-269.
273. Serra, M., Pisu, M. G., Floris, I., Cara,V., Purdy, R. H., and Biggio, G. (2003). Social isolation-induced increase in the sensitivity of rats to the steroidogenic effect of ethanol. J. Neurochem. 85, 257-263.
274. Serra, M., Pisu, M. G., Littera, M., Papi, G., Sanna, E., Tuveri, F., Usala, L., Purdy, R. H., and Biggio, G. (2000). Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain. J. Neurochem. 75, 732-740.
275. Shen, H., Gong, Q. H., Aoki, C., Yuan, M., Ruderman, Y., Dattilo, M., Williams, K., and Smith, S. S. (2007). Reversal of neurosteroid effects at alpha4beta2delta GABAA receptors triggers anxiety at puberty. Nat. Neurosci. 10, 469-477.
276. Shen, W., Mennerick, S., Covey, D. F., and Zorumski, C. F. (2000). Pregnenolone sulfate modulates inhibitory synaptic transmission by enhancing GABA(A) receptor desensitization. J. Neurosci. 20, 3571-3579.
277. Shen, W., Mennerick, S., Zorumski, E. C., Covey, D. F., and Zorumski, C. F. (1999). Pregnenolone sulfate and dehydroepiandrosterone sulfate inhibit GABA-gated chloride currents in Xenopus oocytes expressing picrotoxin-insensitive GABA(A) receptors. Neuropharmacology 38, 267-271.
278. Shu, H. J., Eisenman, L. N., Jinadasa, D., Covey, D. F., Zorumski, C. F., and Mennerick, S. (2004). Slow actions of neuroactive steroids at GABAA receptors. J. Neurosci. 24, 6667-6675.
279. Shumaker, S. A., Legault, C., Kuller, L., Rapp, S. R., Thal, L., Lane, D. S., Fillit, H., Stefanick, M. L., Hendrix, S. L., Lewis, C. E., Masaki, K., and Coker, L. H. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291, 2947-2958.
280. Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones, B. N. III, Assaf, A. R., Jackson, R. D., Kotchen, J. M., Wassertheil-Smoller, S., and Wactawski-Wende, J. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289, 2651-2662.
281. Sieghart, W. (1992). GABAA receptors: ligand-gated Clion channels modulated by multiple drugbinding sites. Trends Pharmacol. Sci. 13, 446-450.
282. Sieghart, W. (2000). Unraveling the function of GABA(A) receptor subtypes. Trends Pharmacol. Sci. 21, 411-413.
283. Sieghart, W., and Sperk, G. (2002). Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr. Top. Med. Chem. 2, 795-816.
284. Sivilotti, L., and Nistri,A. (1991). GABA receptor mechanisms in the central nervous system. Prog. Neurobiol. 36, 35-92.
285. Smart,T. G. (1992). A novel modulatory binding site for zinc on the GABAA receptor complex in cultured rat neurones. J. Physiol. (Lond.) 447, 587-625.
286. Smith, M. C., and Riskin, B. J. (1991). The clinical use of barbiturates in neurological disorders. Drugs 42, 365-378.
287. Smith, S. S., Gong, Q. H., Hsu, F. C., Markowitz, R. S., ffrench-Mullen, J. M., and Li, X. (1998). GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392, 926-930.
288. Smith, S. S., Shen, H., Gong, Q. H., and Zhou, X. (2007). Neurosteroid regulation of GABA(A) receptors: focus on the alpha4 and delta subunits. Pharmacol. Ther. 116, 58-76.
289. Soares, C. N., Cohen, L. S., Otto, M. W., and Harlow, B. L. (2001). Characteristics of women with premenstrual dysphoric disorder (PMDD) who did or did not report history of depression: a preliminary report from the Harvard Study of Moods and Cycles. J. Womens Health Gend. Based Med. 10, 873-878.
290. Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Del Parigi, A., Baldassarre, G., Scapicchio, P., Scafato, E., Amodio, M., Capurso, A., and Panza, F. (2007). Alcohol consumption, mild cognitive impairment, and progression to dementia. Neurology 68, 1790-1799.
291. Sousa, A., and Ticku, M. K. (1997). Interactions of the neurosteroid dehydroepiandrosterone sulfate with the GABA(A) receptor complex reveals that it may act via the picrotoxin site. J. Pharmacol. Exp. Ther. 282, 827-833.
292. Sperk, G., Schwarzer, C., Tsunashima, K., Fuchs, K., and Sieghart, W. (1997). GABA(A) receptor subunits in the rat hippocampus I: immunocytochemical distribution of 13 subunits. Neuroscience 80, 987-1000.
293. Stell, B. M., Brickley, S. G., Tang, C. Y., Farrant, M., and Mody, I. (2003). Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proc. Natl. Acad. Sci. U.S.A. 100, 14439-14444.
294. Stell, B. M., and Mody, I. (2002). Receptors with different affinities mediate phasic and tonic GABA(A) conductances in hippocampal neurons. J. Neurosci. 22, RC223.
295. Stoffel-Wagner, B. (2003). Neurosteroid biosynthesis in the human brain and its clinical implications. Ann. N. Y. Acad. Sci. 1007, 64-78.
296. Stromberg, J., Backstrom, T., and Lundgren, P. (2005). Rapid non-genomic effect of glucocorticoid metabolites and neurosteroids on the gammaaminobutyric acid-A receptor. Eur. J. Neurosci. 21, 2083-2088.
297. Stromberg, J., Haage, D., Taube, M., Backstrom, T., and Lundgren, P. (2006). Neurosteroid modulation of allopregnanolone and GABA effect on the GABA-A receptor. Neuroscience 143, 73-81.
298. Stromstedt, M., Warner, M., Banner, C. D., MacDonald, P. C., and Gustafsson, J. A. (1993). Role of brain cytochrome P450 in regulation of the level of anesthetic steroids in the brain. Mol. Pharmacol. 44, 1077-1083.
299. Sun, C., Sieghart, W., and Kapur, J. (2004). Distribution of alpha1, alpha4, gamma2, and delta subunits of GABAA receptors in hippocampal granule cells. Brain Res. 1029, 207-216.
300. Sunderland, T., Merril, C. R., Harrington, M. G., Lawlor, B. A., Molchan, S. E., Martinez, R., and Murphy, D. L. (1989). Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet 2, 570.
301. Sundstro,I. I.,and Backstrom,T. (1999). Citalopram increases pregnanolone sensitivity in patients with premenstrual dysphoric disorder. Acta Physiol. Scand. 167 A6-A7.
302. Sundstrom, I., Andersson, A., Nyberg, S., Ashbrook, D., Purdy, R. H., and Backstrom, T. (1998). Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67, 126-138.
303. Sundstrom, I., Ashbrook, D., and Backstrom, T. (1997). Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology 22, 25-38.
304. Sundstrom Poromaa, I., Smith, S., and Gulinello, M. (2003). GABA receptors, progesterone and premenstrual dysphoric disorder. Arch. Womens Ment. Health 6, 23-41.
305. Sur, C., Farrar, S. J., Kerby, J., Whiting, P. J., Atack, J. R., and McKernan, R. M. (1999). Preferential coassembly of alpha4 and delta subunits of the gamma-aminobutyric acidA receptor in rat thalamus. Mol. Pharmacol. 56, 110-115.
306. Sveindottir, H., and Backstrom, T. (2000). Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet. Gynecol. Scand. 79, 405-413.
307. Szabadics,J.,Varga,C.,Molnar,G.,Olah, S., Barzo, P., and Tamas, G. (2006). Excitatory effect of GABAergic axoaxonic cells in cortical microcircuits. Science 311, 233-235.
308. Thompson, S. A., Bonnert, T. P., Cagetti, E., Whiting, P. J., and Wafford, K. A. (2002). Overexpression of the GABA(A) receptor epsilon subunit results in insensitivity to anaesthetics. Neuropharmacology 43, 662-668.
309. Thompson, S. A., Whiting, P. J., and Wafford, K. A. (1996). Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination. Br. J. Pharmacol. 117, 521-527.
310. Timby, E., Balgard, M., Nyberg, S., Spigset, O., Andersson, A., Porankiewicz-Asplund, J., Purdy, R. H., Zhu, D., Backstrom, T., and Poromaa, I. S. (2006). Pharmacokinetic and behavioral effects of allopregnanolone in healthy women. Psychopharmacology (Berl.) 186, 414-424.
311. Tossman, U., Jonsson, G., and Ungerstedt, U. (1986). Regional distribution and extracellular levels of amino acids in rat central nervous system. Acta Physiol. Scand. 127, 533-545.
312. Turkmen, S., Lofgren, M., Birzniece, V., Backstrom, T., and Johansson, I. M. (2006). Tolerance development to Morris water maze test impairments induced by acute allopregnanolone. Neuroscience 139, 651-659.
313. Turkmen, S., Lundgren, P., Birzniece, V., Zingmark, E., Backstrom, T., and Johansson, I. M. (2004). 3beta- 20beta-dihydroxy-5alpha-pregnane (UC1011). Antagonism of the GABA potentiation and the learning impairment induced in rats by allopregnanolone. Eur. J. Neurosci. 20, 1604-1612.
314. Upasani, R. B., Yang, K. C., Acosta- Burruel, M., Konkoy, C. S., McLel- lan, J. A., Woodward, R. M., Lan, N. C., Carter, R. B., and Hawkinson, J. E. (1997). 3 alpha-Hydroxy-3 beta- (phenylethynyl)-5 beta-pregnan-20- ones: synthesis and pharmacological activity of neuroactive steroids with high affinity for GABAA receptors. J. Med. Chem. 40, 73-84.
315. Valera, S., Ballivet, M., and Bertrand, D. (1992). Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 89, 9949-9953.
316. van Rijnsoever, C., Tauber, M., Choulli, M. K.,Keist,R., Rudolph,U., Mohler, H., Fritschy, J. M., and Crestani, F. (2004). Requirement of alpha5- GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J. Neurosci. 24, 6785-6790.
317. Vanover, K. E., Rosenzweig-Lipson, S., Hawkinson, J. E., Lan, N. C., Belluzzi, J. D., Stein, L., Barrett, J. E., Wood, P. L., and Carter, R. B. (2000). Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha, 21-dihydroxy- 3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid(A) receptors. J. Pharmacol. Exp. Ther. 295, 337-345.
318. Verdoorn, T. A., Draguhn, A., Ymer, S., Seeburg, P. H., and Sakmann, B. (1990). Functional properties of recombinant rat GABAA receptors depend upon subunit composition. Neuron 4, 919-928.
319. Vicini, S., Losi, G., and Homanics, G. E. (2002). GABA(A) receptor delta subunit deletion prevents neurosteroid modulation of inhibitory synaptic currents in cerebellar neurons. Neuropharmacology 43, 646-650.
320. Vincze,G.,Almos,P.,Boda,K.,Dome,P., Bodi, N., Szlavik, G., Magloczki, E., Pakaski, M., Janka, Z., and Kalman, J. (2007). Risk factors of cognitive decline in residential care in Hungary. Int. J. Geriatr. Psychiatry 22, 1208-1216.
321. Wallner, M., Hanchar, H. J., and Olsen, R. W. (2003). Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans. Proc. Natl. Acad. Sci. U.S.A. 100, 15218-15223.
322. Wang, M., Backstrom, T., Sundstrom, I., Wahlstrom, G., Olsson, T., Zhu, D., Johansson, I. M., Bjorn, I., and Bixo, M. (2001). Neuroactive steroids and central nervous system disorders. Int. Rev. Neurobiol. 46, 421-459.
323. Wang, M., He, Y., Eisenman, L. N., Fields, C., Zeng, C. M., Mathews, J., Benz, A., Fu, T., Zorumski, E., Steinbach, J. H., Covey, D. F., Zorumski, C. F., and Mennerick, S. (2002). 3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J. Neurosci. 22, 3366-3375.
324. Wang, M., Rahman, M., Zhu, D., and Bäckström, T. (2006). Pregnenolone sulfate and zinc inhibit recombinant rat GABAA receptor through different channel property. Acta physiol. (Oxf.)188, 153-163.
325. Wang, M., Seippel, L., Purdy, R. H., and Backstrom, T. (1996). Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum preg- nenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20- one. J. Clin. Endocrinol. Metab. 81, 1076-1082.
326. Wang, M. D., Backstrom, T., and Landgren, S. (2000). The inhibitory effects of allopregnanolone and pregnanolone on the population spike, evoked in the rat hippocampal CA1 stratum pyramidale in vitro, can be blocked selectively by epiallopregnanolone. Acta Physiol. Scand. 169, 333-341.
327. Wang, M. D., Rahman, M., Zhu, D., Johansson, I. M., and Backstrom, T. (2007). 3Beta-hydroxysteroids and pregnenolone sulfate inhibit recombinant rat GABA(A) receptor through different channel property. Eur. J. Pharmacol. 557, 124-131.
328. Wardell, B., Marik, P. S., Piper, D., Rutar, T., Jorgensen, E. M., and Bamber, B. A. (2006). Residues in the first transmembrane domain of the Caenorhabditis elegans GABA(A) receptor confer sensitivity to the neurosteroid pregnenolone sulfate. Br. J. Pharmacol. 148, 162-172.
329. Weinbroum, A. A., Szold, O., Ogorek, D., and Flaishon, R. (2001). The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature. Eur. J. Anaesthesiol. 18, 789-797.
330. Welberg, L. A., and Seckl, J. R. (2001). Prenatal stress, glucocorticoids and the programming of the brain. J. Neuroendocrinol. 13, 113-128.
331. Whiting, P. J. (2003a). GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov. Today 8, 445-450.
332. Whiting, P. J. (2003b). The GABAA receptor gene family: new opportunities for drug development. Curr. Opin. Drug Discov. Devel. 6, 648-657.
333. Wieland, S., Belluzzi, J. D., Stein, L., and Lan, N. C. (1995). Comparative behavioral characterization of the neuroactive steroids 3 alpha- OH,5 alpha-pregnan-20-one and 3 alpha-OH,5 beta-pregnan-20-one in rodents. Psychopharmacology (Berl.) 118, 65-71.
334. Wieland, S., Lan, N. C., Mirasedeghi, S., and Gee, K. W. (1991). Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-o1-20- one. Brain Res. 565, 263-268.
335. Wihlback, A. C., Sundstrom-Poromaa, I., and Backstrom, T. (2006). Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. Psychopharmacology (Berl.) 186, 388-401.
336. Wohlfarth, K. M., Bianchi, M. T., and Macdonald, R. L. (2002). Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit. J. Neurosci. 22, 1541-1549.
337. Wolkowitz, O. M., Reus, V. I., Roberts, E., Manfredi, F., Chan, T., Ormiston, S., Johnson, R., Canick, J., Brizendine, L., and Weingartner, H. (1995). Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann. N. Y. Acad. Sci. 774, 337-339.
338. Woodhull, A. M. (1973). Ionic blockage of sodium channels in nerve. J. Gen. Physiol. 61, 687-708.
339. Woodward, R. M., Polenzani, L., and Miledi, R. (1992). Effects of steroids on gamma-aminobutyric acid receptors expressed in Xenopus oocytes by poly(A)+ RNA from mammalian brain and retina. Mol. Pharmacol. 41, 89-103.
340. Wu, F. S., Gibbs, T. T., and Farb, D. H. (1991). Pregnenolone sulfate: a positive allosteric modulator at the Nmethyl-D-aspartate receptor. Mol. Pharmacol. 40, 333-336.
341. Wu, Y., Wang, W., and Richerson, G. B. (2003). Vigabatrin induces tonic inhibition via GABA transporter reversal without increasing vesicular GABA release. J. Neurophysiol. 89, 2021-2034.
342. Yamada, J., Okabe, A., Toyoda, H., Kilb, W., Luhmann, H. J., and Fukuda, A. (2004). Cl- uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1. J. Physiol. (Lond.) 557, 829-841.
343. Yang, L., Omori, K., Otani, H., Suzukawa, J., and Inagaki, C. (2003). GABAC receptor agonist suppressed ammonia-induced apoptosis in cultured rat hippocampal neurons by restoring phosphorylated BAD level. J. Neurochem. 87, 791-800.
344. Yee, B. K., Hauser, J., Dolgov, V. V., Keist, R., Mohler, H., Rudolph, U., and Feldon, J. (2004). GABA receptors containing the alpha5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear. Eur. J. Neurosci. 20, 1928-1936.
345. Yeung, J. Y., Canning, K. J., Zhu, G., Pennefather, P., MacDonald, J. F., and Orser, B. A. (2003). Tonically activated GABAA receptors in hippocampal neurons are high-affinity, low-conductance sensors for extracellular GABA. Mol. Pharmacol. 63, 2-8.
346. Yu, R., Follesa, P., and Ticku, M. K. (1996). Down-regulation of the GABA receptor subunits mRNA levels in mammalian cultured cortical neurons following chronic neurosteroid treatment. Brain Res. Mol. Brain Res. 41, 163-168.
347. Yu, R., and Ticku, M. K. (1995a). Effects of chronic pentobarbital treatment on the GABAA receptor complex in mammalian cortical neurons. J. Pharmacol. Exp. Ther. 275, 1442-1446.
348. Yu, R., and Ticku, M. K. (1995b). Chronic neurosteroid treatment decreases the efficacy of benzodiazepine ligands and neurosteroids at the gamma-aminobutyric acidA receptor complex in mammalian cortical neurons. J. Pharmacol. Exp. Ther. 275, 784-789.
349. Zhu, W. J., and Vicini, S. (1997). Neurosteroid prolongs GABAA channel deactivation by altering kinetics of desensitized states. J. Neurosci. 17, 4022-4031.
350. Zorumski, C. F., Mennerick, S., Isenberg, K. E., and Covey, D. F. (2000). Potential clinical uses of neuroactive steroids. Curr. Opin. Investig. Drugs 1, 360-369.